Tuesday’s Top Stocks From TradersWire
The major indices tacked on another winning
day after a great run last week. That’s good, but it
also makes me a little nervous. With the Nasdaq up seven straight days, you have
to wonder when the pullback will begin. Be careful with your new longs and keep
your stops in. Now, three stocks for Tuesday:
A Level Three
(
LVLT |
Quote |
Chart |
News |
PowerRating) director bought 200,000
shares at $2. Low-priced stocks are always investor favorites and you can bet
this will get some interest. Just use good money management please.
Astrazeneca’s
(
AZN |
Quote |
Chart |
News |
PowerRating) Crestor may have serious side effects, according
to the American Heart Association. This should send the stock lower at the open.
If the gap down is really large, it’s possible to try a quick long, but
keep in mind these can be tricky.
Genentech
(
DNA |
Quote |
Chart |
News |
PowerRating) said that Phase III
data showed that its drug Lucentis maintained or improved vision in patients
with macular degeneration. This stock should gap up on Tuesday; look to buy in a
pullback on the 5-minute chart.
Brice